MedPath

OBAGI-C RX SYSTEM NORMAL-DRY

OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION KIT

Approved
Approval ID

892bbe2c-cc50-4aea-99f1-0bcd1151f266

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 2, 2013

Manufacturers
FDA

OMP, INC.

DUNS: 790553353

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYDROQUINONE, OCTINOXATE AND ZINC OXIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62032-518
Product Classification
G
Generic Name
HYDROQUINONE, OCTINOXATE AND ZINC OXIDE
Product Specifications
Effective DateJanuary 10, 2013
FDA Product Classification

Drug Labeling Information

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 1/2/2013

Questions or comments?

1.800.636.7546
Monday–Friday 9 a.m.-4 p.m. Pacific Time

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OBAGI-C RX SYSTEM NORMAL-DRY - FDA Drug Approval Details